Ambrugger P, Stoeva I, Biebermann H, Torresani T, Leitner C, Grüters A
Otto Heubner Zentrum für Kinder- und Jugendmedizin, Pädiatrische Endokrinologie, CVK, Humboldt University, Berlin, Germany.
Eur J Endocrinol. 2001 Jul;145(1):19-24. doi: 10.1530/eje.0.1450019.
It is suggested that iodide organification defects account for 10% of all cases with congenital hypothyroidism (CH). One candidate gene for these defects is the thyroid peroxidase (TPO) gene.
Exons 2, 8-10 and 14 of the TPO gene were examined in 30 patients with permanent CH without a family history of CH. This group was characterized by the presence of an orthotopic thyroid gland and elevated TSH levels.
The mutational screening was performed by single-strand conformational polymorphism followed by sequence analysis of fragments with abnormal migration patterns and by restriction enzyme analysis.
In four patients we were able to identify mutations on both alleles which have not been described so far. One patient was a carrier of a new homozygous point mutation in exon 9 resulting in an exchange from Leu to Pro at codon 458. Another patient was found to be compound heterozygous for two mutations, a 20 bp duplication in exon 2 and a new mutation in exon 9 (Arg491His). Two brothers of consanguineous parents showed a homozygous T deletion in exon 14 at position 2512.
Our findings confirm the genetic heterogeneity of TPO defects and support the suggested prevalence of organification defects.
据推测,碘有机化缺陷占所有先天性甲状腺功能减退症(CH)病例的10%。这些缺陷的一个候选基因是甲状腺过氧化物酶(TPO)基因。
对30例无CH家族史的永久性CH患者的TPO基因外显子2、8 - 10和14进行检测。该组患者的特征为存在异位甲状腺且促甲状腺激素(TSH)水平升高。
通过单链构象多态性进行突变筛查,随后对迁移模式异常的片段进行序列分析以及限制性酶切分析。
在4例患者中,我们能够在两个等位基因上鉴定出迄今尚未描述的突变。1例患者是外显子9中一个新的纯合点突变的携带者,该突变导致第458密码子处的亮氨酸替换为脯氨酸。另1例患者被发现为两个突变的复合杂合子,即外显子2中的20 bp重复和外显子9中的一个新突变(Arg491His)。一对近亲父母的两兄弟在外显子14的第2512位显示纯合性T缺失。
我们的研究结果证实了TPO缺陷的遗传异质性,并支持所提示的有机化缺陷患病率。